NEWS
SOFIE to Commercially Supply FDA-Approved PYLARIFY® (piflufolastat F 18) Injection
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially manufacturing and distributing PYLARIFY® (piflufolastat [...]
Brian Schumer joins SOFIE as Chief Operating Officer
We are excited to welcome Brian Schumer to the SOFIE team. Brian joins SOFIE as a Chief Operating Officer. [...]
SOFIE executes order to purchase a top-of-the line GE PETtrace 890
SOFIE has placed a purchase order for GE Healthcare’s top-of-the-line PETtrace 890 dual-particle cyclotron. The machine will be installed [...]
SOFIE affiliate, iTheranostics, executes agreement for its promising library of Fibroblast Activation Protein (FAP) targeted theranostics
Novartis has acquired global development and commercial rights to therapeutic applications for iTheranostics' library of FAP-targeted drugs licensed from [...]
SOFIE Inc. enters into partnership with AUGMENTICON™
AUGMENTICON™, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools for a cost-effective, high-quality manufacturing of (radio-)pharmaceuticals, announces the formation [...]
SOFIE announces promotion of Mike Parisi to Vice President of Sales & Marketing
Mike brings nearly 25 years of Nuclear Medicine, Sales and Management experience to SOFIE. Mike has been with our [...]